PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist Counseling Cuts Chemotherapy Admissions in Single-Center QI Study

pharmacist-led counselingoncology pharmacychemotherapyhospital admissionsfebrile neutropeniacost avoidancepatient satisfactionquality improvementsupportive carepre-post study Oncology Pharmacy

Background Information

Pharmacist-led counseling slashes chemo admissions and boosts satisfaction.

This study shows how pharmacist-led counseling can significantly improve outcomes for chemotherapy patients. The intervention reduced hospital admissions by 34.4%, achieved 94.4% patient satisfaction, and saved $38,850 in costs over five months. Integration of structured pharmacist-led counseling in oncology could reduce admissions and improve patient satisfaction significantly. Pharmacist-led counseling cuts chemotherapy admissions and boosts satisfaction, proving economical.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Assiri A, Median IA, Alshahrani K, Asiri M, Alsaeed O, Asiri A, Abashar M, Ali M, Alsraeya A

Citation: Assiri A, Median IA, Alshahrani K, et al. Pharmacist-led Chemotherapy Counseling: Impact on Hospital Admissions, Patient Satisfaction, and Cost Avoidance - A Prospective Pre-post Quality Improvement Study. Journal of research in pharmacy practice. 2026;15(1):33. doi:10.4103/jrpp.jrpp_24_26

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.